99 related articles for article (PubMed ID: 14008906)
21. [RELATION OF ANTIPLASMIN AND ANTITRYPSIN IN THE BLOOD PLASMA].
MAKI M
Nihon Sanka Fujinka Gakkai Zasshi; 1963 Oct; 15():1143-6. PubMed ID: 14092838
[No Abstract] [Full Text] [Related]
22. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
[No Abstract] [Full Text] [Related]
23. Like fibrin, (DD)E, the major degradation product of crosslinked fibrin, protects plasmin from inhibition by alpha2-antiplasmin.
Lee AY; Fredenburgh JC; Stewart RJ; Rischke JA; Weitz JI
Thromb Haemost; 2001 Mar; 85(3):502-8. PubMed ID: 11307822
[TBL] [Abstract][Full Text] [Related]
24. [ON THE DEFENSIVE REFLEX ANTIPLASMIN SYSTEM IN THE BODY].
KUDRIASHOV BA; KALISHEVSKAIA TM
Biull Eksp Biol Med; 1963 Sep; 56():29-33. PubMed ID: 14124776
[No Abstract] [Full Text] [Related]
25. Investigation of the enzymatic activity in rheumatoid arthritis. II. The antiplasmin action of serum in patients with rheumatoid arthritis.
HAMMARSTEN G; JONSSON E
Acta Med Scand; 1954; 147(5-6):363-6. PubMed ID: 13157912
[No Abstract] [Full Text] [Related]
26. INACTIVATION OF ANTIPLASMIN AND COMPLEMENT C1 IN HUMAN PLASMA RENDERED FIBRINOLYTIC BY SYNTHETIC ORGANIC COMPOUNDS.
VONKAULLA KN
Thromb Diath Haemorrh; 1963 Nov; 10():151-63. PubMed ID: 14081277
[No Abstract] [Full Text] [Related]
27. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. II. ON VARIOUS DISEASES EXCEPT ARTERIOSCLEROSIS].
MATSUDA T
Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():590-7. PubMed ID: 14098708
[No Abstract] [Full Text] [Related]
28. [Antithrombin III and alpha 2-plasmin inhibitor in DIC--the significance of their levels and existence of complexes as diagnostic indicators].
Tsuda T; Hayashi H; Tsurumi N; Kuroda M; Takai Y; Kimura I
Rinsho Ketsueki; 1985 Mar; 26(3):332-40. PubMed ID: 3162051
[No Abstract] [Full Text] [Related]
29. [Evaluation of the assay for alpha 2PI and alpha 2PI-plasmin complex using the one-step sandwich method (EIA)].
Aoki N; Takenaga T; Hasegawa H; Oguma Y; Kobayashi N; Sakata Y; Fujimaki M; Ikematsu S; Kuroso K; Matsuda T
Rinsho Byori; 1987 Nov; 35(11):1275-81. PubMed ID: 2965268
[No Abstract] [Full Text] [Related]
30. The autoimmune blistering skin disease bullous pemphigoid. The presence of plasmin/alpha 2-antiplasmin complexes in skin blister fluid indicates plasmin generation in lesional skin.
Kramer MD; Reinartz J
J Clin Invest; 1993 Aug; 92(2):978-83. PubMed ID: 7688770
[TBL] [Abstract][Full Text] [Related]
31. [ON THE ORIGIN OF ATONIC HEMORRHAGE AND AFIBRINOGENEMIA, AND ANTIPLASMIN AND ANTITRYPSIN BLOOD DISEASES].
MAKI M
Nihon Sanka Fujinka Gakkai Zasshi; 1963 Nov; 15():1207-10. PubMed ID: 14096727
[No Abstract] [Full Text] [Related]
32. Changes in antiplasmin and plasmin activities during extreme hemodilution and open heart surgery in dogs.
Aasen AO; Gallimore MJ; Lilleaasen P; Lyngaas K; Larsbraaten M; Amundsen E
Eur Surg Res; 1979; 11(3):145-53. PubMed ID: 159822
[TBL] [Abstract][Full Text] [Related]
33. Plasma thrombomodulin and alpha 2-plasmin inhibitor-plasmin complex are elevated in active systemic lupus erythematosus.
Kawakami M; Kitani A; Hara M; Harigai M; Suzuki K; Kawaguchi Y; Ishii H; Kazama M; Kawagoe M; Nakamura H
J Rheumatol; 1992 Nov; 19(11):1704-9. PubMed ID: 1337109
[TBL] [Abstract][Full Text] [Related]
34. Kinetics of the inhibition of plasmin in acidified human plasma.
Lijnen HR; Maes M; Castel M; Samama M; Collen D
Thromb Haemost; 1982 Dec; 48(3):257-9. PubMed ID: 6219470
[TBL] [Abstract][Full Text] [Related]
35. Development of a latex immunoturbidimetric assay for the automated measurement of alpha2 plasmin inhibitor-plasmin complex in human plasma.
Fujimoto T; Nakamura K; Nishihira J
Semin Thromb Hemost; 1999; 25(6):551-6. PubMed ID: 10632477
[TBL] [Abstract][Full Text] [Related]
36. [Increased complexes between protease and protease inhibitor in the plasma from patients with neoplasm].
Okadome T; Maruyama I; Shinmyouzu K; Jounosono M; Osame M
Rinsho Ketsueki; 1988 Dec; 29(12):2283-6. PubMed ID: 2977624
[No Abstract] [Full Text] [Related]
37. AN ACTIVE STEREO-ISOMER (TRANS-FORM) OF AMCHA AND ITS ANTIFIBRINOLYTIC (ANTIPLASMINIC) ACTION IN VITRO AND IN VIVO.
OKAMOTO S; SATO S; TAKADA Y; OKAMOTO U
Keio J Med; 1964 Dec; 13():177-85. PubMed ID: 14279228
[No Abstract] [Full Text] [Related]
38. Carbon monoxide releasing molecule-2 enhances α2-antiplasmin activity.
Malayaman SN; Cohen JB; Machovec KA; Bernhardt BE; Arkebauer MR; Nielsen VG
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):345-8. PubMed ID: 21330914
[TBL] [Abstract][Full Text] [Related]
39. [Urinary-plasmin alpha 2 plasmin inhibitor complex (PIC) in patients with diabetic nephropathy].
Saigo K; Ryo R; Yamaguchi N
Rinsho Byori; 1993 Jul; 41(7):785-8. PubMed ID: 8361049
[TBL] [Abstract][Full Text] [Related]
40. [t-PA-PAI-1 complex].
Maruyama I
Nihon Rinsho; 1999 Sep; 57 Suppl():688-90. PubMed ID: 10543214
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
